Thomas Jefferson University is a licensed substance use treatment provider in Philadelphia, PA, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Methadone is available as part of medication assisted treatment for opioid use disorder. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatment
Medications
Methadone used in TreatmentBuprenorphine used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicaidCash or self-payment
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyThe Joint CommissionSAMHSA certification for opioid treatment program (OTP)Drug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
1233 Locust Street, 4th Floor, Philadelphia, PA 19107
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
451 South University Avenue, Philadelphia, PA 19104
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare